BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26925822)

  • 41. The use of azathioprine in severe adult atopic eczema.
    Buckley DA; Baldwin P; Rogers S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):137-40. PubMed ID: 9784039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study.
    Shah N; Alhusayen R; Walsh S; Shear NH
    J Cutan Med Surg; 2018; 22(5):484-487. PubMed ID: 29855201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic therapy of childhood atopic dermatitis.
    Slater NA; Morrell DS
    Clin Dermatol; 2015; 33(3):289-99. PubMed ID: 25889129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
    Ballester I; Silvestre JF; Pérez-Crespo M; Lucas A
    Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of severe pediatric atopic dermatitis with methotrexate: A retrospective review.
    Anderson K; Putterman E; Rogers RS; Patel D; Treat JR; Castelo-Soccio L
    Pediatr Dermatol; 2019 May; 36(3):298-302. PubMed ID: 30811669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.
    Goujon C; Viguier M; Staumont-Sallé D; Bernier C; Guillet G; Lahfa M; Ferrier Le Bouedec MC; Cambazard F; Bottigioli D; Grande S; Dahel K; Bérard F; Rabilloud M; Mercier C; Nicolas JF
    J Allergy Clin Immunol Pract; 2018; 6(2):562-569.e3. PubMed ID: 28967549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapy of severe atopic dermatitis in adults.
    Deleuran MS; Vestergaard C
    J Dtsch Dermatol Ges; 2012 Jun; 10(6):399-406. PubMed ID: 22606964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective review of the use of azathioprine in severe atopic dermatitis.
    Lear JT; English JS; Jones P; Smith AG
    J Am Acad Dermatol; 1996 Oct; 35(4):642-3. PubMed ID: 8859304
    [No Abstract]   [Full Text] [Related]  

  • 50. The use of methotrexate for treating childhood atopic dermatitis: a multicenter retrospective study.
    Taieb Y; Baum S; Ben Amitai D; Barzilai A; Greenberger S
    J Dermatolog Treat; 2019 May; 30(3):240-244. PubMed ID: 30109960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A.
    Reinhard T; Möller M; Sundmacher R
    Cornea; 1999 Nov; 18(6):645-51. PubMed ID: 10571292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country.
    Ordóñez Rubiano MF; Arenas CM; Chalela JG
    Int J Dermatol; 2018 Jul; 57(7):799-803. PubMed ID: 29700815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methotrexate vs. ciclosporin in the treatment of severe atopic dermatitis in children: a critical appraisal.
    Tsakok T; Flohr C
    Br J Dermatol; 2014 Mar; 170(3):496-8; discussion 498-9. PubMed ID: 24617431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
    Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
    Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
    Riis JL; Vestergaard C; Hjuler KF; Iversen L; Jakobsen L; Deleuran MS; Olsen M
    BMJ Open; 2016 Nov; 6(11):e011870. PubMed ID: 27836869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?
    Alexander H; Patton T; Jabbar-Lopez ZK; Manca A; Flohr C
    F1000Res; 2019; 8():. PubMed ID: 30774935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atopic dermatitis: Kids are not just little people.
    Awasthi S; Rothe MJ; Eichenfield LF
    Clin Dermatol; 2015; 33(6):594-604. PubMed ID: 26686011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azathioprine for atopic dermatitis.
    Meggitt SJ; Reynolds NJ
    Clin Exp Dermatol; 2001 Jul; 26(5):369-75. PubMed ID: 11488818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review.
    Blake SC; Murrell DF
    Pediatr Dermatol; 2019 Nov; 36(6):843-853. PubMed ID: 31566785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
    Fuggle NR; Bragoli W; Mahto A; Glover M; Martinez AE; Kinsler VA
    J Am Acad Dermatol; 2015 Jan; 72(1):108-14. PubMed ID: 25440430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.